ORIC

ORIC Pharmaceuticals Inc.

Price

$14.65

return (12m)

52.60%

p/e

-10.53

p/bv

3.88

DIVIDEND YIELD

0.00%

ORIC price

ORIC Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ORIC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

34.65%

3 months

73.17%

1 year

52.60%

2 years

45.05%

5 years

-24.33%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ORIC

Valuation

P/E

-10.53

Sector -4.38

Industry -4.38

P/BV

3.88

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-26.94

Sector -263.09

Industry -263.09

EV/EBIT

-26.78

Sector -702.90

Industry -702.90

P/EBITDA

-9.54

Sector -4.39

Industry -4.39

P/EBIT

-9.47

Sector -4.73

Industry -4.73

P/Total Assets

3.65

Sector 1.49

Industry 1.49

P/Net Current Assets

5.91

Sector -11.70

Industry -11.70

P/Working Capital

5.84

Sector -3.19

Industry -3.19

EPS

-1.30

Sector -2.14

Industry -2.14

BVPS

3.53

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-36.81%

Sector -65.14%

Industry -65.14%

ROA

-34.68%

Sector -65.53%

Industry -65.53%

ROIC

-123.65%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

13.18

Sector 2.90

Industry 2.90

Net Debt / EBITDA

5.88

Sector -6.07

Industry -6.07

Net Debt / EBIT

5.84

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.69

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.94

Sector 0.41

Industry 0.41

Liabilities/Assets

0.06

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

12.26%

Sector -

Industry -

Fundamentals ORIC

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ORIC ORIC Pharmaceuticals Inc.	$14.65	47.98%	0.00%	-10.53	3.88	-36.81%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ORIC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ORIC Pharmaceuticals

ORIC Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

12 years

Founded: 2014

2020

Time since IPO - 6 years

61

Employees

ORIC Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.48 billion, with shareholders equity totaling $381.26 million.

The company employs approximately 61 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, ORIC Pharmaceuticals Inc. reported $- in revenue, generating net income of $-140.35 million.

Key financial metrics include a P/E ratio of -10.53, a price-to-book (P/B) ratio of 3.88, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ORIC.

Market cap

$1.48 billion

Net worth

$381.26 million

$381,260,000.00

Assets

$404.69 million

$404,690,000.00

Total Shares Outstanding

108.00 million

108,000,000

Average Daily Trading Volume

$1.69 million

$1,693,435.10

Sector

Health Care

Industry

Biotechnology

ORIC

ORIC revenue and profits

Financial Results ORIC

DRAG THE FRAME TO SEE MORE DATA

ORIC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of ORIC Pharmaceuticals (ORIC) today?

A cotação de ORIC Pharmaceuticals (ORIC) hoje está em US$ 14.65, com uma variação de 52.6% em relação ao último ano. A cotação de ORIC Pharmaceuticals (ORIC) iniciou o ano negociando na casa dos US$ 8.18 e hoje está em US$ 14.65. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de ORIC Pharmaceuticals (ORIC) e dados de ações do Ibovespa e mercados internacionais.

Quando ORIC Pharmaceuticals (ORIC) paga dividendos?

ORIC Pharmaceuticals (ORIC) não distribuiu dividendos no último ano.

Is ORIC Pharmaceuticals (ORIC) a good investment?

Atualmente, ORIC Pharmaceuticals (ORIC) está cotada a US$ 14.65, com um P/L de -10.53, representando um desvio de -590% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 52.6 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 52.60%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ORIC Pharmaceuticals (ORIC) stock?

Investir em ações de ORIC Pharmaceuticals (ORIC) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of ORIC Pharmaceuticals (ORIC) yield today?

A rentabilidade de ORIC Pharmaceuticals (ORIC) foi de 34.65% no último mês, 52.60% no último ano e -24.33% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de ORIC Pharmaceuticals (ORIC) hoje, o investimento total seria de US$ 1,465.00, com base na cotação atual de US$ 14.65.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,235.59
Em 5 anos: US$ 1,108.57
Em 10 anos: US$ 1,465.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ORIC

ORIC Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ORIC

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ORIC WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ORIC Pharmaceuticals

ORIC Pharmaceuticals Inc.

United States

12 years

2020

61

PROFIT X PRICE ORIC

Financial Results ORIC

ORIC cash flow

Asset, Revenue and Profit Growth - ORIC

ORIC balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions